Abstract
Advanced glycation end-products (AGEs) are non-enzymatic protein and amino acid adducts as well as DNA adducts which form from dicarbonyls and glucose. AGE formation is enhanced in diabetes and is associated with the development of diabetic complications. In the current review, we discuss mechanisms that lead to enhanced AGE levels in the context of diabetes and diabetic complications. The methylglyoxal-detoxifying glyoxalase system as well as alternative pathways of AGE detoxification are summarized. Therapeutic approaches to interfere with different pathways of AGE formation are presented.
| Original language | English |
|---|---|
| Article number | 984 |
| Journal | International Journal of Molecular Sciences |
| Volume | 18 |
| Issue number | 5 |
| DOIs | |
| State | Published - 5 May 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 3-deoxyglucosone
- Advanced glycation end-products
- Aldose reductase
- Diabetes
- Glyoxal
- Glyoxalase
- Methylglyoxal
Fingerprint
Dive into the research topics of 'Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver